Attovia Therapeutics

About Attovia Therapeutics

Attovia is a biotherapeutics company focused on developing innovative medicines for immune-mediated diseases using their proprietary ATTOBODY® technology. Their mission is to create first-in-class and best-in-class therapeutics with breakthrough efficacy, addressing unmet needs in patient care where existing treatments are insufficient.

Products & Services

ATTOBODY Platform:A proprietary biologics platform leveraging spatial positioning technology for biparatopic target engagement, offering ultra-high affinity, best-in-class potency, and the potential for quarterly or less frequent dosing. It supports the development of multispecific biologics with tunable half-life.

Pipeline of Biotherapeutics:A range of biotherapeutics targeting immune-mediated diseases, developed using the ATTOBODY platform to achieve innovative mechanisms of action.

Specialties

Immune-mediated disease therapeutics Multispecific biologics Biparatopic target engagement High-throughput biologics discovery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 90000000 MR: - FA: $90 million FAN: 90000000	D: 2025-04-15 FD: 2025-04-15	12 investors
2	RT: Series B T: - FT: Series B	A: 105000000 MR: - FA: $105 million FAN: 105000000	D: 2024-05-09 FD: 2024-05-09	10 investors
3	RT: Series A T: - FT: Series A	A: 60000000 MR: - FA: $60 million FAN: 60000000	D: 2024-02-08 FD: 2024-02-08	-
4	RT: Series A T: - FT: Series A	A: 60000000 MR: - FA: 60 million FAN: 60000000	D: 2023-06-20 FD: 2023-06-20	3 investors

Series C Latest

2025-04-15

$90.0M

12 investors (Pro only)

Series B 2024-05-09

$105.0M

Series A 2024-02-08

$60.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tao Fu, MBA, M.S.

Chief Executive Officer

S

Steven Chan

Chief Financial Officer

H

Hubert Chen, M.D., M.P.H.

Chief Medical Officer

Z

Zaneta Odrowaz, Ph.D.

Chief Business Officer

P

Petter Veiby, Ph.D.

Chief Scientific Officer

H

Hangjun Zhan, Ph.D.

Chief Technology Officer

View 17 more team members with Pro

Unlock Full Team Directory

Recent News